Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second‐generation drug‐eluting stents for coronary artery disease: A systematic review and meta‐analysis of randomized trials
Khaled M. Ziada(Cleveland Clinic), David J. Moliterno(Cleveland Clinic), Richard Charnigo(University of Kentucky), Ahmed Abdel‐Latif(University of Kentucky)
Cited by 22
Related Papers
Extent and Direction of Arterial Remodeling in Stable Versus Unstable Coronary Syndromes
|Circulation|2000|751
High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults
|Circulation|2001|681
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
|The Lancet|2009|298
Arterial remodeling and coronary artery disease: the concept of “dilated” versus “obstructive” coronary atherosclerosis
|Journal of the American College of Cardiology|2001|290